Related Experiment Video
Updated: Jan 15, 2026

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Cardiac disease mechanobiology: advances using hiPSC-CMs
Georgina Aluoch Stephanie1, Alison Schroer Vander Roest2
1Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
Engineered cardiac microenvironments using biomaterials and human-induced pluripotent stem cells (hiPSCs) offer advanced models for studying cardiovascular diseases (CVDs). These systems improve understanding of cardiac mechanobiology and disease mechanisms beyond traditional methods.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Stem Cell Biology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death, necessitating better human-specific models for understanding pathophysiology.
- Current animal models often fail to replicate human cardiac features, and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exhibit immaturity and heterogeneity.
- Studying cardiac mechanobiology, crucial for disease progression, is challenging in humans due to limitations in existing models.
Purpose of the Study:
- To review advancements in cardiac microenvironment engineering for modeling cardiac mechanobiology and diseases.
- To explore the potential of engineered biomaterial systems and hiPSC-CMs in studying human cardiac pathophysiology.
- To highlight the integration of biomaterials and genome editing for improved in vitro cardiac models.
Main Methods:
- Review of recent literature on cardiac microenvironment engineering.
- Discussion of human-induced pluripotent stem cells (hiPSCs) and their derived cardiomyocytes (hiPSC-CMs).
- Exploration of biomaterial-based in vitro systems, including hydrogels, for mimicking native cardiac tissue.
Main Results:
- Engineered cardiac microenvironments using biomaterials can recapitulate the mechanical and biochemical cues of native tissue.
- hiPSC-CMs, when cultured in engineered environments, show potential for modeling disease-specific phenotypes.
- Advanced platforms integrating biomaterials and genome editing offer improved cellular maturation and mechanotransduction studies.
Conclusions:
- Engineered cardiac microenvironments represent a significant advancement for modeling cardiac mechanobiology and diseases.
- These sophisticated in vitro models hold promise for overcoming limitations of animal and traditional cell culture models.
- Future research integrating biomaterials and genome editing could revolutionize cardiac disease research and lead to precise interventions.
More Related Videos
06:42Author Spotlight: Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: May 26, 2023
09:43Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025